|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Ionis Pharmaceuticals
| | | Phone: | (760) 931-9200 | Fax: | (760) 603-2700 | Year Established: | 1989 | Ticker: | IONS | Exchange: | NASDAQ | Main Contact: | Damien McDevitt, CBO | | Other Contacts: | Richard S. Geary, Ph.D., Senior VP, Development Brett P. Monia, Ph.D., Senior VP, Antisense Drug Discovery C. Frank Bennett, Ph.D., Senior VP, Research Elizabeth L. Hougen, Senior VP & CFO Stanley T. Crooke, M.D., Ph.D., Chairman & CEO
| | Company Description | Ionis Pharmaceuticals, formerly Isis Pharma, is the leading company in RNA-targeted drug discovery and development focused on developing drugs for patients who have the highest unmet medical needs, such as those patients with severe and rare diseases. Using its proprietary antisense technology, Ionis has created a large pipeline of first-in-class or best-in-class drugs, with over a dozen drugs in mid- to late-stage development. Drugs currently in Phase 3 development include volanesorsen, a drug Ionis is developing and plans to commercialize through its wholly owned subsidiary, Akcea Therapeutics, to treat patients with familial chylomicronemia syndrome and familial partial lipodystrophy; IONIS-TTRRx, a drug Ionis is developing with GSK to treat patients with all forms of TTR amyloidosis; and nusinersen, a drug Ionis is developing with Biogen to treat infants and children with spinal muscular atrophy. Ionis' patents provide strong and extensive protection for its drugs and technology. | |
|
|
|
|
|